Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Using peptides without a proper diagnosis risks treating the wrong problem while a serious underlying condition goes unaddressed
Activation of the GLP-1 receptor in microglia, GABAergic interneurons and astrocytes stimulates several intracellular pathways including the PI3K/Akt, cAMP/PKA/CREB, and P-Akt/p-eNOS and subsequently confers neuroprotective effects through inhibition of gp91/CHOP, Nrf2/HO-1, Bax/Bcl-2/caspase3/PARP, NF-B/ICAM-1, and JAK2/STAT3
Many of the current challenges with GLP-1s are driven by persistent shortages, arbitrarily high costs of medications, providers inability to truly personalize treatments based on their individual patients responses, and a one-size-fits-all approach to dosing
Injured tissue heals faster when it has an adequate blood supply delivering oxygen and nutrients
